---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-23-000051"
form_type: "8-K/A"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2023-10-12T23:59:59+00:00"
generated_at: "2026-06-10T01:19:19.427995+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Haemonetics to acquire OpSens for $2.90/share cash via arrangement

## Summary
- Haemonetics to acquire all outstanding shares of OpSens via plan of arrangement under Quebec Business Corporations Act.
- Consideration of $2.90 per share in cash; termination fee of $12.075 million payable by OpSens in certain circumstances.
- Support and voting agreements with certain shareholders to vote in favor of the arrangement resolution.
- Transaction subject to shareholder approval, Quebec Superior Court order, and regulatory clearances.

## SEC filing metadata
- accession: 0000313143-23-000051
- form_type: 8-K/A
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2023-10-12T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314323000051/0000313143-23-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314323000051/hae-20231010.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-23-000051
- JSON: https://secwatch.observer/filing/0000313143-23-000051.json
- Plain text: https://secwatch.observer/filing/0000313143-23-000051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.